您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > CT7001 hydrochloride(ICEC0942 hydrochloride)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
CT7001 hydrochloride(ICEC0942 hydrochloride)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
CT7001 hydrochloride(ICEC0942 hydrochloride)图片
包装与价格:
包装价格(元)
10mM (in 1mL DMSO)电议
5mg电议
10mg电议
25mg电议
50mg电议
100mg电议

产品介绍
CT7001 hydrochloride (ICEC0942 hydrochloride) (CT7001 hydrochloride) 是一种有效的,选择性的,ATP 竞争性的,具有口服活性的 CDK7 抑制剂,IC50 为 41 nM。 CT7001 hydrochloride (ICEC0942 hydrochloride) 的选择性分别是 CDK1、CDK2(IC50 为 578 nM)、CDK5 和 CDK9 的 45、15、230 和 30 倍。 CT7001 hydrochloride (ICEC0942 hydrochloride) 抑制乳腺癌细胞系的生长,GI50 值在 0.2-0.3 之间 μM. CT7001 hydrochloride (ICEC0942 hydrochloride) 具有抗肿瘤作用。

Kinase experiment:

The purified recombinant CDK2/cycE1 and CDK7/CycH/MAT1 are used in the assay. Kinase assays are performed. Briefly, Rb-CTF and RNA Polymerase II peptide is used for CDK2 and CDK7 kinase assays, respectively. A luciferase assay is used to determine ATP remaining at the end of the kinase reaction, which provides a measure of kinase activity. GraphPad Prism Software is used to generate the IC50 values for each CDK[1].

产品描述

CT7001 hydrochloride is a selective CDK7 inhibitor, with IC50s of 41 nM and 578 nM for CDK7/CycH/MAT1 and CDK2/cycE1, respectively.

CT7001 (ICEC0942) is a selective CDK7 inhibitor, with IC50s of 41 nM and 578 nM for CDK7/CycH/MAT1 and CDK2/cycE1, respectively[1].

[1]. Hazel P, et al. Inhibitor Selectivity for Cyclin-Dependent Kinase 7: A Structural, Thermodynamic, and Modelling Study. ChemMedChem. 2017 Mar 7;12(5):372-380.